Department of Health and Human Services September 9, 2014 – Federal Register Recent Federal Regulation Documents

Georgia Tuberculosis Outbreak Among Homeless
Document Number: 2014-21455
Type: Notice
Date: 2014-09-09
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
The Centers for Disease Control and Prevention (CDC) located within the United States Department of Health and Human Services (HHS) announces a notice of award to the Georgia Department of Public Health, Tuberculosis (TB) Program. This award will be in the amount of $419,095.00. The purpose of this award is to halt the further spread of a drug- resistant strain of tuberculosis associated with multiple homeless shelters in Fulton County, Georgia.
Proposed Data Collections Submitted for Public Comment and Recommendations
Document Number: 2014-21379
Type: Notice
Date: 2014-09-09
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Agency Forms Undergoing Paperwork Reduction Act Review
Document Number: 2014-21377
Type: Notice
Date: 2014-09-09
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Advisory Committee Renewals; Correction
Document Number: 2014-21369
Type: Notice
Date: 2014-09-09
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is correcting a notice entitled ``Advisory Committee Renewals'' that appeared in the Federal Register of August 25, 2014 (79 FR 50658). The document announced the renewal of certain FDA advisory committees by the Commissioner of Food and Drugs. The table in the document contained several errors. This document corrects those errors.
Center for Scientific Review; Notice of Closed Meetings
Document Number: 2014-21344
Type: Notice
Date: 2014-09-09
Agency: Department of Health and Human Services, National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Document Number: 2014-21343
Type: Notice
Date: 2014-09-09
Agency: Department of Health and Human Services, National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meetings
Document Number: 2014-21342
Type: Notice
Date: 2014-09-09
Agency: Department of Health and Human Services, National Institutes of Health
National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meeting
Document Number: 2014-21341
Type: Notice
Date: 2014-09-09
Agency: Department of Health and Human Services, National Institutes of Health
National Eye Institute; Notice of Meeting
Document Number: 2014-21340
Type: Notice
Date: 2014-09-09
Agency: Department of Health and Human Services, National Institutes of Health
National Cancer Institute; Notice of Closed Meeting
Document Number: 2014-21339
Type: Notice
Date: 2014-09-09
Agency: Department of Health and Human Services
Office of the Director; Notice of Charter Renewal
Document Number: 2014-21338
Type: Notice
Date: 2014-09-09
Agency: Department of Health and Human Services, National Institutes of Health
Exploring the Expansion of Conditional Approval to Appropriate Categories of New Animal Drugs
Document Number: 2014-21227
Type: Notice
Date: 2014-09-09
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing that it is beginning the exploration process described in a stated performance goal in the Animal Drug User Fee Amendments of 2013 (ADUFA III) goals letter. Consistent with the performance goal, the FDA is inviting comments in regard to the Agency exploring the use of statutory changes to expand the use of conditional approval beyond new animal drugs intended for minor species or for minor uses in major species to additional categories of new animal drugs as appropriate.
Exploring the Feasibility of Pursuing Statutory Revisions and Other Modifications to Existing Procedures and Requirements Related to the Approval of Combination Drug Medicated Feeds
Document Number: 2014-21226
Type: Notice
Date: 2014-09-09
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing that it is beginning the exploration process described in a stated performance goal in the Animal Drug User Fee Amendments of 2013 (ADUFA III) goals letter. Consistent with the performance goal, FDA is inviting comments in regard to the Agency exploring the use of statutory changes to modify the current requirement that the use of multiple new animal drugs in a combination drug medicated feed be the subject of an approved new animal drug application (NADA). The Agency also is inviting comment on potential changes to procedures and requirements related to the NADA approval process for such products that can be accomplished under the Agency's existing statutory authority.